M&M Biomedical Appoints Brandon Burris To Its Board

Carton Service-Packaging Changes Name To Pharma Packaging Solutions

Carton Service’s division Carton Service-Packaging Insights has changed its name to Pharma Packaging Solutions. The company said that the new name is a result of customer inputs and

Ortho Kinematics Relocates To Austin, Texas From San Francisco

Ortho Kinematics develops The KineGraph VMA (Vertebral Motion Analyzer), a new functional diagnostic test for the spine that uses fluoroscopy to capture the spine in motion.

FDA Approves Roxane ANDA For Perindopril Erbumine Tablets

Roxane Laboratories (Roxane) has received approval for its Abbreviated New Drug Application (ANDA) for Perindopril Erbumine tablets, 2mg, 4mg and 8mg from the FDA. Perindopril Erbumine tablets are

Genmab Sees Positive Impact On Net Financial Items

Genmab has posted revenues of $86m for the nine month period ended September 30, 2009. In the same period of 2008, Genmab recognised revenues of $131m. An operating

AMT Reports Positive Result From DMD Study

Amsterdam Molecular Therapeutics (AMT) has reported positive result of duchenne muscular dystrophy (DMD) in an animal model with its proprietary gene therapy. Reportedly, the proof of concept studies

Duke University Enters Into Research, Drug Development Partnership With Jubilant Organosys

Duke University and Jubilant Organosys, through its subsidiary, Jubilant Biosys, have signed a Letter of Intent to develop a multi-faceted partnership that will expedite translation of discoveries by

China Medical Technologies Announces Approval From China For Leukemia BCR/ABL FISH Probe

The company claims that the Leukemia BCR/ABL FISH Probe is a molecular diagnostic test kit that uses DNA probes for accurate detection of Philadelphia translocation, which is a

Antares Seals License, Asset Purchase Agreements With Ferring

Antares Pharma (Antares) has entered into a license and an asset purchase agreement with Ferring International Center. Under the terms of the exclusive license agreement Ferring obtained rights

Access Unveils Update On MuGard Launch In North America

Access Pharmaceuticals (Access) has provided an update on its North American commercial launch of MuGard, an FDA approved treatment for oral mucositis. Access plans to commercially launch MuGard